This inventor holds 50 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 18 EPO patents, primarily in Prosthetic Heart Valves. Top assignees: Medtronic, Inc., Medtronic Cv Luxembourg S.a.r.l., Medtronic Vascular, Inc.. Active years: 1994-2026.
Location History:
- Minneapolis, MN (US) (2013)
- Santa Ana, CA (US) (2015 - 2018)
- Fullerton, CA (US) (1994 - 2023)
Company Filing History:
44 out of 8,933 
4 out of 41 
1 out of 1,006 
Years Active: 1994-2026
Areas of Expertise:
Title: The Innovative Contributions of Carol Elsa Eberhardt in Cardiovascular Devices
Introduction: Carol Elsa Eberhardt is a prominent innovator based in Fullerton, California, known for her significant contributions to the field of cardiovascular technology. With an impressive portfolio of 48 patents, her work focuses on improving medical devices that enhance heart health. Eberhardt’s dedication to innovation has paved the way for advancements in stent technology, particularly for prosthetic heart valves.
Latest Patents: Among her latest inventions are groundbreaking patents related to stents for prosthetic heart valves. One of her key inventions describes a stented valve that features a generally tubular stent structure characterized by a longitudinal axis and two opposite ends. This design includes a series of commissure support structures that are spaced from the ends and align parallel to the longitudinal axis. Furthermore, it incorporates at least one structural wire positioned between adjacent support structures and wing portions that extend toward the ends of the stent. Eberhardt's inventions contribute significantly to the field by integrating a valve structure within this stent for enhanced functionality. Another important patent outlines a single-piece stent construction with multiple commissure posts, extending upwardly from a solid ring along a defined bend line, illustrating her commitment to simplifying and improving heart valve technologies.
Career Highlights: Carol Eberhardt has had a distinguished career, notably working with Medtronic, Inc. and Medtronic CV Luxembourg S.a.r.l., where she applied her innovative mindset to develop cutting-edge cardiovascular solutions. Her work has had a lasting impact on the medical field, particularly in enhancing the safety and effectiveness of heart-related procedures.
Collaborations: Throughout her career, Eberhardt has collaborated with talented professionals in the industry. Her notable coworkers include Janice Lynn Shay and Timothy R. Ryan, who have shared her vision for improving healthcare through innovative device design and engineering.
Conclusion: Carol Elsa Eberhardt stands out as a leading inventor in the realm of cardiovascular technology, with her numerous patents reflecting her commitment to advancing healthcare. Her work on stented valves and related innovations continues to influence the design and functionality of prosthetic heart devices, ultimately improving patient outcomes. As she forges ahead in her career, Eberhardt's contributions will undoubtedly leave a lasting legacy in the field of medical innovations.